The UAB Heersink School of Medicine is proud to announce the 19 winners of the 2025 Dean's Excellence Awards for Faculty.

The UAB Medicine Leadership Development Office recently recognized eight individuals in its sixth cohort of Sharing Authentically to Inspire and Lead (SAIL). The spring 2025 graduates were honored at a ceremony on April 8.

The American College of Cardiology (ACC), in partnership with the American Association of Cardiologists of Indian Origin, has named Navin Nanda, M.D., distinguished professor of Medicine and Cardiovascular Disease, as the new ACC International Service Award namesake.

Gregory Payne, M.D., Ph.D., associate professor of Medicine, has been named the latest recipient of the school’s Featured Discovery award. This recognition celebrates notable research contributions made by faculty and highlights the impact of their scientific advancements.

The National Institute of Diabetes and Digestive and Kidney Diseases reports that chronic kidney disease affects more than one in seven adults in the United States, an estimated 35.5 million Americans. Additionally, the risk of developing kidney disease increases with conditions such as diabetes or high blood pressure.

Timmy Lee, M.D., MSPH, will serve as the next division director for the UAB Division of Nephrology, effective July 1, 2025.

As NTM cases rise, the UAB Nontuberculous Mycobacterial (NTM) Program, led by Bryan Garcia, M.D., in partnership with German Henostroza, M.D., has formed a multidisciplinary team to provide individualized care, improve diagnosis, and enhance treatment outcomes for patients with NTM.

Rebekah Weil, M.D., has been named the associate division director for medical education for the Division of General Internal Medicine and Population Science.

Rui Lu, Ph.D., associate professor in the Department of Medicine, has been named the latest recipient of the school's Featured Discovery award. This recognition celebrates notable research contributions made by faculty and highlights the impact of their scientific advancements.

Sandeep Bodduluri, Ph.D., is working to use artificial intelligence (AI) to improve health care processes and the patient experience. Through courses offered by the Marnix E. Heersink Institute for Biomedical Innovation, he is sharing his knowledge with clinicians at UAB and abroad, emphasizing the importance of interaction between clinicians and engineers in AI research and development.

Dana Rizk, M.D., has been appointed associate dean for Clinical Trials and Cynthia Joiner, Ph.D., MPH, R.N., has been named assistant dean for Clinical Research Operations in the Heersink School of Medicine, effective March 1, 2025. Both of these newly created roles will work closely with Senior Associate Dean for Clinical and Translational Research, Orlando Gutiérrez, M.D., to lead the Heersink School of Medicine’s efforts to advance clinical trials.

Just weeks after discharge, the patient is back at the hospital. This time, the infection has worsened, sepsis has set in, and emergency surgery is needed. A preventable outcome had intervention come sooner.

Martina Gonzalez-Gomez, M.D., M.Sc., program manager for the Global Neurosurgery program in the Department of Neurosurgery, and James Johnston, M.D., professor in the Department of Neurosurgery and director of the Pediatric Neurosurgery division, co-instruct the Global Surgery course. In 2023, we met with Gonzalez-Gomez and Johnston to learn more about their vision for the course, which launched with the introduction of the UAB Master of Science in Global Health (MSGH) program offered by the UAB Heersink School of Medicine and the UAB School of Public Health (SOPH).

UAB Medicine’s Leadership Development Office welcomed 16 individuals in its 10th cohort of Institute for Leadership in January 2025. UAB Medicine Institute for Leadership is a flagship program of the Leadership Development Office, aimed at empowering leaders across UAB and the UAB Health System. It features an initial DISC assessment and a robust agenda of guest speakers from executive-level leadership positions at UAB, including Institute alumni, throughout the program.

The UAB Heersink School of Medicine is proud to announce the 2025 Pittman Scholars. This prestigious honor recognizes assistant professors who have held that rank for fewer than five years for their exceptional research achievements and potential for future contributions to their fields. Named after former School of Medicine Dean James A. Pittman Jr., M.D., this award highlights the school's commitment to fostering innovation and excellence in medical research.

November 2024 marked 20 years since the establishment of the Evelyn F. McKnight Brain Institute (EMBI) at UAB. The institute was made possible by a generous gift from the McKnight Brain Research Foundation (MBRF), matched by the university, to support research in cognitive aging and age-related memory loss. Ronald Lazar, Ph.D., professor in the UAB Department of Neurology, has been director of the institute since 2017.

Twenty-two UAB leaders graduated among the ninth cohort of the UAB Medicine Institute for Leadership on Dec. 11, 2024. Institute for Leadership is a flagship program of the UAB Medicine Leadership Development Office, an organization dedicated to providing tools and training to empower UAB Medicine’s leaders and the individuals and groups they manage.

Nita Limdi, PharmD, Ph.D., MSPH, FAHA, has been appointed associate dean for Genomic Medicine, effective Oct. 1. Limdi will lead efforts to expand UAB's Genomic Medicine program, focusing on interdisciplinary collaborations, securing grant funding, and enhancing partnerships. Her extensive research in pharmacogenomics and leadership in national consortia underscore her commitment to advancing genomic medicine.

The AI in Medicine and Nursing Symposium, hosted by the UAB Heersink School of Medicine, UAB Medicine, UAB School of Health Professions, UAB School of Nursing, and Maastricht University Faculty of Science and Engineering, concluded successfully, bringing together leading experts, researchers, and industry representatives to explore the transformative potential of artificial intelligence (AI) in health care.

Twenty-two UAB employees recently graduated from the Emerging Leaders Series (ELS) fall 2024 leadership development program. The program, presented by UAB Medicine’s Leadership Development Office (LDO), recognized its second cohort of graduates at a ceremony on Nov. 7.